TNSN03124A1 - ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONS - Google Patents

ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONS

Info

Publication number
TNSN03124A1
TNSN03124A1 TNPCT/EP2002/005725A TNSN03124A TNSN03124A1 TN SN03124 A1 TNSN03124 A1 TN SN03124A1 TN SN03124 A TNSN03124 A TN SN03124A TN SN03124 A1 TNSN03124 A1 TN SN03124A1
Authority
TN
Tunisia
Prior art keywords
treatment
anticholinergic agent
receptor agonist
adenosine
combined
Prior art date
Application number
TNPCT/EP2002/005725A
Other languages
French (fr)
Inventor
Michael Yeadon
Roisin A Armstrong
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0129275A external-priority patent/GB0129275D0/en
Priority claimed from GB0210238A external-priority patent/GB0210238D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN03124A1 publication Critical patent/TNSN03124A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENTION CONCERNE UNE ASSOCIATION D'UN AGONISTE DE RECEPTEUR D'ADENOSINE A2A SELECTIF ET D'UN AGENT ANTICHOLINERGIQUE POUR L'ADMINISTRATION SIMULTANEE, SEQUENTIELLE OU DISTINCTE PAR INHALATION DANS LE TRAITEMENT D'UNE MALADIE OBSTRUCTIVE DES VOIES AERIENNES OU D'UNE AUTRE MALADIE INFLAMMATOIRE, SOUS RESERVE QUE L'AGENT ANTICHOLINERGIQUE NE SOIT PAS UN SEL DE TIOTROPIUM.THE PRESENT INVENTION CONCERNS A COMBINATION OF A SELECTIVE ADENOSINE A2A RECEPTOR AGONIST AND AN ANTICHOLINERGIC AGENT FOR SIMULTANEOUS, SEQUENTIAL OR DISTINCT ADMINISTRATION BY INHALATION IN THE TREATMENT OF OBSTRUCTIVE AIRWAY OR OTHER DISEASE INFLAMMATORY DISEASE, PROVIDED THAT THE ANTICHOLINERGIC AGENT IS NOT A SALT OF TIOTROPIUM.

TNPCT/EP2002/005725A 2001-05-25 2002-05-24 ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONS TNSN03124A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29384201P 2001-05-25 2001-05-25
GB0129275A GB0129275D0 (en) 2001-12-06 2001-12-06 Pharmaceutical combination
GB0210238A GB0210238D0 (en) 2002-05-03 2002-05-03 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
TNSN03124A1 true TNSN03124A1 (en) 2005-12-23

Family

ID=42632507

Family Applications (1)

Application Number Title Priority Date Filing Date
TNPCT/EP2002/005725A TNSN03124A1 (en) 2001-05-25 2002-05-24 ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONS

Country Status (4)

Country Link
AR (1) AR036030A1 (en)
EA (1) EA200301153A1 (en)
PE (1) PE20030145A1 (en)
TN (1) TNSN03124A1 (en)

Also Published As

Publication number Publication date
EA200301153A1 (en) 2004-04-29
AR036030A1 (en) 2004-08-04
PE20030145A1 (en) 2003-03-01

Similar Documents

Publication Publication Date Title
TNSN03123A1 (en) PDE 4 INHIBITOR AND ASSOCIATED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES
MXPA03010787A (en) An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases.
NZ522326A (en) Adenosine A2A receptor antagonists
JO2503B1 (en) Benzothiazole derivatives
AU4438601A (en) Therapeutic combinations of antihypertensive and antiangiogenic agents
YU42703A (en) Compounds specific to adenosine a1, a2a and a3 receptor and uses thereof
WO2007064658A3 (en) Safe and effective methods of administering therapeutic agents
WO2009045309A3 (en) Use of v2 receptor antagonists in combination with vasopressinergic agonists
MXPA03009185A (en) Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson s disease.
WO2004096118A3 (en) Composition for improving cognition and memory
BR0105776A (en) Combination treatment for depression, anxiety and psychosis
TNSN03124A1 (en) ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONS
WO2001017558A3 (en) Novel uses of mammalian ccr6 receptors and related reagents
TWI256388B (en) Pharmaceutical combination
ATE277639T1 (en) COMPOSITIONS OF ADENOSINE A1 AGONISTS AND 5HT3 AGONISTS
ATE260118T1 (en) COMPOSITIONS OF ADENOSINE A1 AGONISTS WITH 5HT1 AGONISTS
GB0028245D0 (en) New therapeutic use
BR9912008A (en) Treatment method
WO2001045686A3 (en) Formulations of adenosine a1 agonists
TNSN04102A1 (en) ASSOCIATION OF A SELECTIVE PDE4 INHIBITOR AND A BETA-2 ADRENERGIC RECEPTOR AGONIST
ECSP034863A (en) AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES
HN2002000128A (en) AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS.
EA200301140A1 (en) PDE4 INHIBITOR AND ANTICHOLINERGIC AGENT IN COMBINATION FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF RESPIRATORY WAYS